Search Results

Filter
  • 10-20 of  36,502 results for ""INTERFERON alpha""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A novel TRIM22 gene polymorphism promotes the response to PegIFNα therapy through cytokine-cytokine receptor interaction signaling pathway in chronic hepatitis B.

  • Authors : Wang L; Department of Laboratory Medicine, Fujian Key Laboratory of Laboratory Medicine, Gene Diagnosis Research Center, Fujian Clinical Research Center for Clinical Immunology Laboratory Test, The First Affiliated Hospital, Fujian Medical University , Fuzhou, Fujian, China.; The First Clinical College, Fujian Medical University , Fuzhou, Fujian, China.

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/drug therapy ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/genetics

  • Source: Microbiology spectrum [Microbiol Spectr] 2023 Dec 12; Vol. 11 (6), pp. e0224723. Date of Electronic Publication: 2023 Oct 26.Publisher: ASM Press Country of Publication: United States NLM ID: 101634614 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Engineering a New IFN-ApoA-I Fusion Protein with Low Toxicity and Prolonged Action.

  • Authors : Miroshnichenko S; Federal Research Center of Fundamental and Translational Medicine (FRC FTM), Timakova str., 2, 630117 Novosibirsk, Russia.; Pykhtina M

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/genetics ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/pharmacology ; Apolipoproteins A*

  • Source: Molecules (Basel, Switzerland) [Molecules] 2023 Dec 08; Vol. 28 (24). Date of Electronic Publication: 2023 Dec 08.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

×
Academic Journal

Inhibition of human cytomegalovirus replication by interferon alpha can involve multiple anti-viral factors.

  • Authors : Chowdhury S; Institute of Infection & Immunity, St George's, University of London, London, UK.; Latham KA

Subjects: Cytomegalovirus*/Cytomegalovirus*/Cytomegalovirus*/physiology ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/pharmacology; Humans

  • Source: The Journal of general virology [J Gen Virol] 2023 Dec; Vol. 104 (12).Publisher: Microbiology Society Country of Publication: England NLM ID: 0077340 Publication Model: Print Cited Medium: Internet ISSN: 1465-2099

Record details

×
Academic Journal

Upregulated SPAG6 correlates with increased STAT1 and is associated with reduced sensitivity of interferon-α response in BCR::ABL1 negative myeloproliferative neoplasms.

  • Authors : Ding L; Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Department of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/pharmacology ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/genetics ; Neoplasms*/Neoplasms*/Neoplasms*/genetics

  • Source: Cancer science [Cancer Sci] 2023 Nov; Vol. 114 (11), pp. 4445-4458. Date of Electronic Publication: 2023 Sep 08.Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic

Record details

×
Academic Journal

RanBP2/Nup358 Mediates Sumoylation of STAT1 and Antagonizes Interferon-α-Mediated Antiviral Innate Immunity.

  • Authors : Li J; Department of Immunology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350108, China.; Su L

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/pharmacology ; Virus Diseases*; Humans

  • Source: International journal of molecular sciences [Int J Mol Sci] 2023 Dec 25; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 25.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

[A study of the clinical curative effect of nucleos(t)ide analogues treated to pegylated interferon-α add-on therapy in patients with chronic hepatitis B].

  • Authors : Liang H; Department of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.; Wang C

Subjects: Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/drug therapy ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/therapeutic use ; Polyethylene Glycols*/Polyethylene Glycols*/Polyethylene Glycols*/therapeutic use

  • Source: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology [Zhonghua Gan Zang Bing Za Zhi] 2023 Dec 20; Vol. 31 (12), pp. 1297-1305.Publisher: Chongqing yi ke da xue, di 2 lin chuang xue yuan Bing du xing gan yan yan jiu suo Country of Publication: China NLM ID: 9710009 Publication Model:

Record details

×
Academic Journal

Desmethoxycurcumin aids IFNα's anti-HBV activity by antagonising CRYAB reduction and stabilising IFNAR1 protein.

  • Authors : Wei J; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Deng X

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/pharmacology ; Hepatitis B virus*/Hepatitis B virus*/Hepatitis B virus*/physiology; Curcumin/Curcumin/Curcumin/*analogs & derivatives

  • Source: Journal of drug targeting [J Drug Target] 2023 Dec; Vol. 31 (9), pp. 976-985. Date of Electronic Publication: 2023 Nov 16.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312476 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Lactate inhibits interferon-α response in ovarian cancer by inducing STAT1 ubiquitin degradation.

  • Authors : Dong X; Central Laboratory of Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde Foshan), Foshan 528300, Guangdong, China.; Lin C

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/metabolism ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/genetics; Humans

  • Source: International immunopharmacology [Int Immunopharmacol] 2023 Dec; Vol. 125 (Pt A), pp. 111099. Date of Electronic Publication: 2023 Oct 31.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Chronic IFNα treatment induces leukopoiesis, increased plasma succinate and immune cell metabolic rewiring.

  • Authors : Yennemadi AS; TB Immunology Group, Department of Clinical Medicine, Trinity Translational Medicine Institute, School of Medicine, Trinity College Dublin, The University of Dublin, Dublin, Ireland.; Jameson G

Subjects: Succinic Acid*/Succinic Acid*/Succinic Acid*/metabolism ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/pharmacology; Humans

  • Source: Cellular immunology [Cell Immunol] 2023 Aug; Vol. 390, pp. 104741. Date of Electronic Publication: 2023 Jun 20.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 1246405 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Elevated Levels of Interferon-α Act Directly on B Cells to Breach Multiple Tolerance Mechanisms Promoting Autoantibody Production.

  • Authors : Ferri DM; Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada.; Nassar C

Subjects: Interferon-alpha* ; Lupus Erythematosus, Systemic*; Animals

  • Source: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2023 Sep; Vol. 75 (9), pp. 1542-1555. Date of Electronic Publication: 2023 Jun 30.Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 10-20 of  36,502 results for ""INTERFERON alpha""